Achieve Life Sciences (ACHV) Reports In-Line Q4 EPS

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.28), in-line with the analyst estimate of ($0.28).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Akari Therapeutics to present ADC platform at five September conferences
• StoneX Reiterates Buy Rating on DoorDash Inc. (DASH)